Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication.

Lu P, Wang S, Franzen CA, Venkataraman G, McClure R, Li L, Wu W, Niu N, Sukhanova M, Pei J, Baldwin DA, Nejati R, Wasik MA, Khan N, Tu Y, Gao J, Chen Y, Ma S, Larson RA, Wang YL. Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication. Blood Cancer J. 2021 02 18; 11(2):39.

View in: PubMed